Belföldi hírek

About International Osteoporosis Foundation (IOF) IOF is a registered not-for-profit, non-governmental foundation based in Switzerland. IOF has been granted Roster Consultative Status with the Economic and Social Council of the United Nations. IOF functions as a global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone health and prevent fractures due to osteoporosis. www.iofbonehealth.org About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 7 500 people in approximately 40 countries, the company generated revenue of € 4.9 billion in 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news About University of Oxford Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the fourth year running, and at the heart of this success is our groundbreaking research and innovation. Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions. About The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) NDORMS is a multi-disciplinary department focusing on discovering the causes of musculoskeletal and inflammatory conditions to deliver excellent and innovative care that improves people's quality of life. The largest European academic department in its field, NDORMS is part of the Medical Sciences Division of the University of Oxford and is a rapidly growing community of more than 500 orthopaedic surgeons, rheumatologists and scientists all working in the field of musculoskeletal disorders. www.ndorms.ox.ac.uk CONTACTS: International Osteoporosis Foundation: Laura Misteli, Communications Editor, +41(0)78 8571777, lmisteli@iofbonehealth.org NDORMS, University of Oxford: Josie Eade, Communications Officer, +44 1865 225136, josie.eade@ndorms.ox.ac.uk Amgen, Thousand Oaks: Megan Fox, 805-447-1423 (media) Trish Rowland, 805-447-5631 (media) UCB: Scott Fleming, Bone Communications, UCB, +44 7702777378, scott.fleming@ucb.com References (1.) International Osteoporosis Foundation. IOF Compendium of Osteoporosis 2nd Edition. http://www.worldosteoporosisday.org/sites/default/WOD-2019/resources/compendium/2019-IOF-Compendium-of-Osteoporosis-WEB.pdf. Accessed March 11, 2020. (2.) Burge et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007; Mar;22 3:465-475. (3). Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726-1733. (4.) Reginster JY, Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006;38 (2 Suppl 1):S4-S9 (5.) International Osteoporosis Foundation. Capture The Fracture - A global campaign to break the fragility fracture cycle (October 2012). http://share.iofbonehealth.org/WOD/2012/report/WOD12-Report.pdf. Accessed March 11, 2020. (6.) Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust. 2004;180:S18-S22. (7.) Kanis et al. A meta-analysis of previous fracture and fracture risk. Bone 2004 35;375-82 (8.) Akesson et al. Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013 Aug;24(8):2135-52 (9.) Ganda et al. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis Osteoporos Int (2013) 24:393-406 ------------------------------------------------------------------- Az OTS internetes oldalán található hírek, közlemények, fotók a forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett anyagot tartalmának torzítása nélkül, félreérthetőséget, rosszindulatú következtetéseket kizáró, az eredeti szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni. Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI által szó szerint továbbított tartalomért minden esetben a beadó a felelős. © Copyright MTI nonprofit Zrt. Az OTS szolgáltatással kapcsolatban további információt a (06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus levelező címen kaphat.